Browsing: GLP1

NEW YORK, Aug 2 (Reuters) – Nora Nye, 58, is refreshing her wardrobe as she sizes down for the first time in over three decades after losing 80 pounds on weight-loss drug Mounjaro. Earlier this year, the Denver bankruptcy lawyer walked into a Macy’s and found herself overwhelmed

The World Health Organization (WHO) has urged people to use GLP-1 receptor agonists only under the supervision of qualified healthcare professionals. The advisory follows the rapid global rise in the use of these medicines, particularly for weight loss, and growing concerns over misuse and purchases from unregulated